Impact of empagliflozin on diabetic kidney disease

被引：1
|
作者：
Koya, Daisuke [1 ,2 ]
机构：
[1] Dept Diabetol Endocrinol Div Anticipatory Mol Foo, Kanazawa Medical Univers, Ishikawa, Japan
[2] Kanazawa Med Univ, Dept Diabetol & Endocrinol, Div Anticipatory Mol Food Sci & Technol, Uchinada, Ishikawa, Japan
来源：
JOURNAL OF DIABETES INVESTIGATION | 2017年 / 8卷 / 05期
关键词：
D O I：
10.1111/jdi.12615
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：658 / 660
页数：3
相关论文
共 50 条
  • [41] Empagliflozin in chronic kidney disease: nephroprotection is independent of albuminuria, primary kidney disease, and baseline eGFR
    Zoccali, Carmine
    Mallamaci, Francesca
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (01): : 5 - 8
  • [42] Different Effects of Empagliflozin on Markers of Mineral-Bone Metabolism in Diabetic and Non-Diabetic Patients with Stage 3 Chronic Kidney Disease
    Masajtis-Zagajewska, Anna
    Holub, Tomasz
    Peczek, Katarzyna
    Makowka, Agnieszka
    Nowicki, Michal
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [43] DIABETIC MYONECROSIS IN DIABETIC KIDNEY DISEASE
    Trott, N.
    Dermedgoglou, A.
    Johns, N.
    Pandey, R.
    NEPHROLOGY, 2017, 22 : 74 - 74
  • [44] Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats
    Kuno, Atsushi
    Kimura, Yukishige
    Mizuno, Masashi
    Oshima, Hiroto
    Sato, Tatsuya
    Moniwa, Norihito
    Tanaka, Marenao
    Yano, Toshiyuki
    Tanno, Masaya
    Miki, Takayuki
    Miura, Tetsuji
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] Effect of empagliflozin on urinary albumin excretion and hypoxic injury biomarkers of early phase diabetic kidney disease (EUROBEAT study)
    Makino, H.
    Kasahara, M.
    Kasama, S.
    Ozu, N.
    Takashima, R.
    Noguchi, M.
    Park, H.
    Chen, Q.
    Tsuruya, K.
    Hosoda, K.
    DIABETOLOGIA, 2024, 67 : S5 - S6
  • [46] A Pilot Study Embedding Clinical Pharmacists Within an Interprofessional Nephrology Clinic for the Initiation and Monitoring of Empagliflozin in Diabetic Kidney Disease
    Triantafylidis, Laura K.
    Hawley, Chelsea E.
    Fagbote, Christopher
    Li, Jiahua
    Genovese, Nicole
    Paik, Julie M.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (03) : 428 - 437
  • [47] Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats
    Atsushi Kuno
    Yukishige Kimura
    Masashi Mizuno
    Hiroto Oshima
    Tatsuya Sato
    Norihito Moniwa
    Marenao Tanaka
    Toshiyuki Yano
    Masaya Tanno
    Takayuki Miki
    Tetsuji Miura
    Scientific Reports, 10
  • [48] IMPACT OF HYPONATREMIA ON RENAL FUNCTION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
    Nishizawa, Yoko
    Ogawa, Tetsuya
    Shimada, Miki
    Murakami, Chikako
    Shimizu, Himiko
    Inoue, Tomoko
    Yamashita, Tetsuri
    Kyono, Ai
    Higuchi, Chieko
    Nagano, Nobuo
    Nitta, Kosaku
    Sakura, Hiroshi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [49] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    Ralph A. DeFronzo
    W. Brian Reeves
    Alaa S. Awad
    Nature Reviews Nephrology, 2021, 17 : 319 - 334
  • [50] The impact of chronic kidney disease in diabetic COVID-19 patients
    Chaabouni, Hana
    Bougharriou, Ichrak
    Mnif, Khouloud
    Maazoun, Majdi
    Ben Jemaa, Tarak
    Rekik, Khaoula
    Smaoui, Fatma
    Koubaa, Makram
    Marrakchi, Chakib
    Hammami, Boussayma
    Ben Jemaa, Mounir
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S33 - S33
12345